Radius
is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of osteoporosis, cancer, and endocrine diseases... Read moreRadius
is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of osteoporosis, cancer, and endocrine diseases... Read more
President & CEO
Kelly Martin
News
Jan 04, 2025
Pharmabiz
Radius: Radius Pharma grants Pharmanovia the exclusive commercialization rights to abaloparatide in China and selected Asia Pacific territories
Dec 09, 2024
FinanzNachrichten
Radius: Radius Health: Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement with Theramex Granting Additional Commercialization Rights Including Mexico, Canada, South Africa, Israel, and Russia
Jul 02, 2024
Owler
Radius Health, Inc.: Radius's revenue changed from $2.82B in Feb 2024 to $2.69B in May 2024
Jun 25, 2024
PR-Inside
Press Release: Radius : Radius Pharmaceuticals Announces the Appointment of Renata Sklodowska, ...
Apr 16, 2024
FinanzNachrichten
Radius: Radius Health, Inc.: Radius Announces Presentation of Data on TYMLOS at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Apr 04, 2024
Owler
Radius Health, Inc.: Radius's revenue changed from $2.96B in Nov 2023 to $2.82B in Feb 2024
Jan 05, 2024
Owler
Radius Health, Inc.: Radius's revenue changed from $2.88B in Aug 2023 to $2.96B in Nov 2023
Oct 25, 2023
Owler
Radius Health, Inc.: Radius's revenue changed from $3.49B in Aug 2022 to $2.88B in Aug 2023
Sep 19, 2023
FinanzNachrichten
Radius: EffRx Pharmaceuticals SA: EffRx Pharmaceuticals Signs Exclusive Licensing Agreement With Radius Health To Commercialize BINOSTO In The United States
Aug 14, 2023
Endpoints News
Radius: Radius Pharmaceuticals sells off part of its royalties, milestones in breast cancer drug Orserdu to DRI Healthcare
Radius Competitors
1
2
3
4
5
6
7
8
9
10